These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31206391)

  • 1. Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence.
    Lachance A; Corbeil O; Corbeil S; Chalifour G; Breault AS; Roy MA; Demers MF
    J Clin Psychopharmacol; 2019; 39(4):393-397. PubMed ID: 31206391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports.
    Corbeil O; Corbeil S; Giroux I; Jacques C; Dorval M; Demers MF; Roy MA
    J Clin Psychopharmacol; 2020; 40(2):191-194. PubMed ID: 32134855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.
    Grall-Bronnec M; Sauvaget A; Perrouin F; Leboucher J; Etcheverrigaray F; Challet-Bouju G; Gaboriau L; Derkinderen P; Jolliet P; Victorri-Vigneau C
    J Clin Psychopharmacol; 2016 Feb; 36(1):63-70. PubMed ID: 26658263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial dopamine agonist-induced pathological gambling and impulse-control deficit on low-dose aripiprazole.
    Peterson E; Forlano R
    Australas Psychiatry; 2017 Dec; 25(6):614-616. PubMed ID: 28696131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aripiprazole, gambling disorder and compulsive sexuality].
    Mété D; Dafreville C; Paitel V; Wind P
    Encephale; 2016 Jun; 42(3):281-3. PubMed ID: 26923999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports.
    Gaboriau L; Victorri-Vigneau C; Gérardin M; Allain-Veyrac G; Jolliet-Evin P; Grall-Bronnec M
    Addict Behav; 2014 Mar; 39(3):562-5. PubMed ID: 24315783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.
    Takase M; Kanahara N; Oda Y; Kimura H; Watanabe H; Iyo M
    J Psychopharmacol; 2015 Apr; 29(4):383-9. PubMed ID: 25735995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial agonist therapy in schizophrenia: relevance to diminished criminal responsibility.
    Gavaudan G; Magalon D; Cohen J; Lançon C; Léonetti G; Pélissier-Alicot AL
    J Forensic Sci; 2010 Nov; 55(6):1659-62. PubMed ID: 20579229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Gambling Disorder and Impulse Control Disorder With Aripiprazole, Pramipexole, and Ropinirole: A Pharmacoepidemiologic Study.
    Etminan M; Sodhi M; Samii A; Procyshyn RM; Guo M; Carleton BC
    J Clin Psychopharmacol; 2017 Feb; 37(1):102-104. PubMed ID: 27930495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Cases of De Novo Pathological Gambling Associated With Aripiprazole.
    Chen HY; Ma CH; Liu CC
    Clin Neuropharmacol; 2019; 42(3):101-102. PubMed ID: 31082834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escalation of Gambling Associated With Aripiprazole: A Case Report and Literature Review.
    Giri YR; Peteru SR
    J Psychiatr Pract; 2019 Mar; 25(2):139-145. PubMed ID: 30849063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden.
    Wolfschlag M; Håkansson A
    PLoS One; 2021; 16(6):e0252516. PubMed ID: 34061895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program.
    Corbeil O; Corbeil S; Dorval M; Carmichael PH; Giroux I; Jacques C; Demers MF; Roy MA
    CNS Drugs; 2021 Apr; 35(4):461-468. PubMed ID: 33713298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brexpiprazole: a new leaf on the partial dopamine agonist branch.
    Hope J; Castle D; Keks NA
    Australas Psychiatry; 2018 Feb; 26(1):92-94. PubMed ID: 29017334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Pathological Gambling and Impulse Control Disorders With Dopamine Agonists: A Retrospective Cohort Study.
    Sodhi M; Etminan M; Carleton B; Samii A
    J Clin Psychopharmacol; 2019; 39(6):675-676. PubMed ID: 31688453
    [No Abstract]   [Full Text] [Related]  

  • 16. Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.
    Fusaroli M; Raschi E; Giunchi V; Menchetti M; Rimondini Giorgini R; De Ponti F; Poluzzi E
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):727-736. PubMed ID: 35639870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    Moore TJ; Glenmullen J; Mattison DR
    JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological gambling and the treatment of psychosis with aripiprazole: case reports.
    Smith N; Kitchenham N; Bowden-Jones H
    Br J Psychiatry; 2011 Aug; 199(2):158-9. PubMed ID: 21804151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole: impulse control disorders. Pathological gambling.
    Prescrire Int; 2016 Nov; 25(176):271. PubMed ID: 30730124
    [No Abstract]   [Full Text] [Related]  

  • 20. Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
    Takekita Y; Fabbri C; Kato M; Nonen S; Sakai S; Sunada N; Koshikawa Y; Wakeno M; Okugawa G; Kinoshita T; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):579-88. PubMed ID: 26016467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.